SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Credit Suisse Maintains Neutral on Phibro Animal Health, Lowers Price Target to $23

Credit Suisse maintains Phibro Animal Health (NASDAQ:PAHC) with a Neutral and lowers the price target from $25 to $23.

Benzinga · 05/08/2020 14:45

Credit Suisse maintains Phibro Animal Health (NASDAQ:PAHC) with a Neutral and lowers the price target from $25 to $23.